Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system, Cytokine Growth Factor Rev, vol.15, pp.353-366, 2004. ,
SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production, Nat Cell Biol, vol.8, pp.843-848, 2006. ,
Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes, Cytokine, vol.28, pp.67-74, 2004. ,
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha, Gastroenterology, vol.128, pp.376-392, 2005. ,
Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents, Inflamm Bowel Dis, vol.13, pp.1323-1332, 2007. ,
Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain, FASEB J, vol.13, pp.1575-1585, 1999. ,
Interleukin-15 protects from lethal apoptosis in vivo, Nat Med, vol.3, pp.1124-1128, 1997. ,
Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist, J Immunol, vol.173, pp.1681-1688, 2004. ,
Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17), J Biol Chem, vol.279, pp.40368-40375, 2004. ,
IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation, J Exp Med, vol.205, pp.1213-1225, 2008. ,
The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha, J Mol Biol, vol.382, pp.1-12, 2008. ,
Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of Il-15 action through Il-15R beta/gamma. Herperagonist IL-15 x IL-15R alpha fusion proteins, J Biol Chem, vol.281, pp.1612-1619, 2006. ,
Increased numbers of interleukin-15-expressing cells in active ulcerative colitis, Am J Gastroenterol, vol.91, pp.1789-1794, 1996. ,
Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease, Gastroenterology, vol.114, pp.1237-1243, 1998. ,
Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease, J Gastroenterol, vol.40, pp.128-136, 2005. ,
Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice, Gut, vol.55, pp.334-416, 2006. ,
IL-15 protects intestinal epithelial cells, Eur J Immunol, vol.36, pp.2697-2699, 2006. ,
Identification of an interleukin-15alpha receptor-binding site on human interleukin-15, J Biol Chem, vol.279, pp.24313-24322, 2004. ,
The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer, Cancer Res, vol.68, pp.3907-3914, 2008. ,
How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha, Mol Cell Biol, vol.28, pp.4851-4861, 2008. ,
The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease, Pharmacogenet Genomics, vol.16, pp.727-734, 2006. ,
Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis, Clin Rheumatol, vol.4, pp.505-509, 2007. ,
IL-15 exacerbates collageninduced arthritis with an enhanced CD4? T cell response to produce IL-17, Eur J Immunol, vol.37, pp.2744-2752, 2007. ,
Soluble IL-15 receptor alphachain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology, J Immunol, vol.160, pp.5654-5660, 1998. ,
Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis, Gastroenterology, vol.116, pp.557-565, 1999. ,
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease, Gut, vol.53, pp.70-77, 2004. ,
IL-15/IL-15R alpha intracellular trafficking in human cells and protection from apoptosis, Ann N Y Acad Sci, vol.876, pp.236-245, 1999. ,
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial, Ann Intern Med, vol.146, pp.829-838, 2007. ,